[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Recombinant Antibody Sales Market Report Forecast 2017-2021

April 2017 | 126 pages | ID: GAF24A79701EN
S&P Consulting

US$ 3,040.00 US$ 3,800.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
A.G.Scientific
Abbott Diagnostics
Agilent Technologies
BD Biosciences
Beckman Coulter
bioMerieux
Bio-Rad Laboratories
F. Hoffmann-La Roche
Gallus Immunotech

Product Segment Analysis:
Type 1
Type 2
Type 3

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
    It provides distinctive graphics and exemplified analysis of major market segments
1 RECOMBINANT ANTIBODY MARKET OVERVIEW

1.1 Product Overview and Scope of Recombinant Antibody
1.2 Classification of Recombinant Antibody
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Recombinant Antibody
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Recombinant Antibody Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Recombinant Antibody (2012-2021)
  1.5.1 Global Recombinant Antibody Sales and Growth Rate (2012-2021)
  1.5.2 Global Recombinant Antibody Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON RECOMBINANT ANTIBODY INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 RECOMBINANT ANTIBODY MANUFACTURING COST ANALYSIS

3.1 Recombinant Antibody Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Recombinant Antibody

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Recombinant Antibody Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL RECOMBINANT ANTIBODY COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Recombinant Antibody Market Competition by Manufacturers
  5.1.1 Global Recombinant Antibody Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Recombinant Antibody Revenue and Share by Manufacturers (2012-2017)
5.2 Global Recombinant Antibody (Volume and Value) by Type
  5.5.1 Global Recombinant Antibody Sales and Market Share by Type (2012-2017)
  5.5.2 Global Recombinant Antibody Revenue and Market Share by Type (2012-2017)
5.3 Global Recombinant Antibody (Volume and Value) by Regions
  5.3.1 Global Recombinant Antibody Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Recombinant Antibody Revenue and Market Share by Regions (2012-2017)
5.4 Global Recombinant Antibody (Volume) by Application

6 UNITED STATES RECOMBINANT ANTIBODY (VOLUME, VALUE AND SALES PRICE)

6.1 United States Recombinant Antibody Sales and Value (2012-2017)
  6.1.1 United States Recombinant Antibody Sales and Growth Rate (2012-2017)
  6.1.2 United States Recombinant Antibody Revenue and Growth Rate (2012-2017)
  6.1.3 United States Recombinant Antibody Sales Price Trend (2012-2017)
6.2 United States Recombinant Antibody Sales and Market Share by Manufacturers
6.3 United States Recombinant Antibody Sales and Market Share by Type
6.4 United States Recombinant Antibody Sales and Market Share by Application

7 CHINA RECOMBINANT ANTIBODY (VOLUME, VALUE AND SALES PRICE)

7.1 China Recombinant Antibody Sales and Value (2012-2017)
  7.1.1 China Recombinant Antibody Sales and Growth Rate (2012-2017)
  7.1.2 China Recombinant Antibody Revenue and Growth Rate (2012-2017)
  7.1.3 China Recombinant Antibody Sales Price Trend (2012-2017)
7.2 China Recombinant Antibody Sales and Market Share by Manufacturers
7.3 China Recombinant Antibody Sales and Market Share by Type
7.4 China Recombinant Antibody Sales and Market Share by Application

8 EUROPE RECOMBINANT ANTIBODY (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Recombinant Antibody Sales and Value (2012-2017)
  8.1.1 Europe Recombinant Antibody Sales and Growth Rate (2012-2017)
  8.1.2 Europe Recombinant Antibody Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Recombinant Antibody Sales Price Trend (2012-2017)
8.2 Europe Recombinant Antibody Sales and Market Share by Manufacturers
8.3 Europe Recombinant Antibody Sales and Market Share by Type
8.4 Europe Recombinant Antibody Sales and Market Share by Application

9 JAPAN RECOMBINANT ANTIBODY (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Recombinant Antibody Sales and Value (2012-2017)
  9.1.1 Japan Recombinant Antibody Sales and Growth Rate (2012-2017)
  9.1.2 Japan Recombinant Antibody Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Recombinant Antibody Sales Price Trend (2012-2017)
9.2 Japan Recombinant Antibody Sales and Market Share by Manufacturers
9.3 Japan Recombinant Antibody Sales and Market Share by Type
9.4 Japan Recombinant Antibody Sales and Market Share by Application

10 GLOBAL RECOMBINANT ANTIBODY MANUFACTURERS ANALYSIS

10.1 A.G.Scientific
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Abbott Diagnostics
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Agilent Technologies
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 BD Biosciences
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Beckman Coulter
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 bioMerieux
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Bio-Rad Laboratories
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 F. Hoffmann-La Roche
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Gallus Immunotech
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL RECOMBINANT ANTIBODY MARKET FORECAST (2017-2021)

13.1 Global Recombinant Antibody Sales, Revenue Forecast (2017-2021)
13.2 Global Recombinant Antibody Sales Forecast by Regions (2017-2021)
13.3 Global Recombinant Antibody Sales Forecast by Type (2017-2021)
13.4 Global Recombinant Antibody Sales Forecast by Application (2017-2021)

14 APPENDIX


LIST OF TABLES AND FIGURES

Figure Picture of Recombinant Antibody
Table Classification of Recombinant Antibody
Figure Global Sales Market Share of Recombinant Antibody by Type in 2015
Table Applications of Recombinant Antibody
Figure Global Sales Market Share of Recombinant Antibody by Application in 2015
Figure United States Recombinant Antibody Revenue and Growth Rate (2012-2021)
Figure China Recombinant Antibody Revenue and Growth Rate (2012-2021)
Figure Europe Recombinant Antibody Revenue and Growth Rate (2012-2021)
Figure Japan Recombinant Antibody Revenue and Growth Rate (2012-2021)
Figure Global Recombinant Antibody Sales and Growth Rate (2012-2021)
Figure Global Recombinant Antibody Revenue and Growth Rate (2012-2021)
Table Global Recombinant Antibody Sales of Key Manufacturers (2012-2017)
Table Global Recombinant Antibody Sales Share by Manufacturers (2012-2017)
Figure 2015 Recombinant Antibody Sales Share by Manufacturers
Figure 2016 Recombinant Antibody Sales Share by Manufacturers
Table Global Recombinant Antibody Revenue by Manufacturers (2012-2017)
Table Global Recombinant Antibody Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Recombinant Antibody Revenue Share by Manufacturers
Table 2016 Global Recombinant Antibody Revenue Share by Manufacturers
Table Global Recombinant Antibody Sales and Market Share by Type (2012-2017)
Table Global Recombinant Antibody Sales Share by Type (2012-2017)
Figure Sales Market Share of Recombinant Antibody by Type (2012-2017)
Figure Global Recombinant Antibody Sales Growth Rate by Type (2012-2017)
Table Global Recombinant Antibody Revenue and Market Share by Type (2012-2017)
Table Global Recombinant Antibody Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Antibody by Type (2012-2017)
Figure Global Recombinant Antibody Revenue Growth Rate by Type (2012-2017)
Table Global Recombinant Antibody Sales and Market Share by Regions (2012-2017)
Table Global Recombinant Antibody Sales Share by Regions (2012-2017)
Figure Sales Market Share of Recombinant Antibody by Regions (2012-2017)
Figure Global Recombinant Antibody Sales Growth Rate by Regions (2012-2017)
Table Global Recombinant Antibody Revenue and Market Share by Regions (2012-2017)
Table Global Recombinant Antibody Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Recombinant Antibody by Regions (2012-2017)
Figure Global Recombinant Antibody Revenue Growth Rate by Regions (2012-2017)
Table Global Recombinant Antibody Sales and Market Share by Application (2012-2017)
Table Global Recombinant Antibody Sales Share by Application (2012-2017)
Figure Sales Market Share of Recombinant Antibody by Application (2012-2017)
Figure Global Recombinant Antibody Sales Growth Rate by Application (2012-2017)
Figure United States Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure United States Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure United States Recombinant Antibody Sales Price Trend (2012-2017)
Table United States Recombinant Antibody Sales by Manufacturers (2012-2017)
Table United States Recombinant Antibody Market Share by Manufacturers (2012-2017)
Table United States Recombinant Antibody Sales by Type (2012-2017)
Table United States Recombinant Antibody Market Share by Type (2012-2017)
Table United States Recombinant Antibody Sales by Application (2012-2017)
Table United States Recombinant Antibody Market Share by Application (2012-2017)
Figure China Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure China Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure China Recombinant Antibody Sales Price Trend (2012-2017)
Table China Recombinant Antibody Sales by Manufacturers (2012-2017)
Table China Recombinant Antibody Market Share by Manufacturers (2012-2017)
Table China Recombinant Antibody Sales by Type (2012-2017)
Table China Recombinant Antibody Market Share by Type (2012-2017)
Table China Recombinant Antibody Sales by Application (2012-2017)
Table China Recombinant Antibody Market Share by Application (2012-2017)
Figure Europe Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure Europe Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure Europe Recombinant Antibody Sales Price Trend (2012-2017)
Table Europe Recombinant Antibody Sales by Manufacturers (2012-2017)
Table Europe Recombinant Antibody Market Share by Manufacturers (2012-2017)
Table Europe Recombinant Antibody Sales by Type (2012-2017)
Table Europe Recombinant Antibody Market Share by Type (2012-2017)
Table Europe Recombinant Antibody Sales by Application (2012-2017)
Table Europe Recombinant Antibody Market Share by Application (2012-2017)
Figure Japan Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure Japan Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure Japan Recombinant Antibody Sales Price Trend (2012-2017)
Table Japan Recombinant Antibody Sales by Manufacturers (2012-2017)
Table Japan Recombinant Antibody Market Share by Manufacturers (2012-2017)
Table Japan Recombinant Antibody Sales by Type (2012-2017)
Table Japan Recombinant Antibody Market Share by Type (2012-2017)
Table Japan Recombinant Antibody Sales by Application (2012-2017)
Table Japan Recombinant Antibody Market Share by Application (2012-2017)
Table A.G.Scientific Basic Information List
Table A.G.Scientific Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure A.G.Scientific Recombinant Antibody Global Market Share (2012-2017)
Table Abbott Diagnostics Basic Information List
Table Abbott Diagnostics Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Diagnostics Recombinant Antibody Global Market Share (2012-2017)
Table Agilent Technologies Basic Information List
Table Agilent Technologies Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Agilent Technologies Recombinant Antibody Global Market Share (2012-2017)
Table BD Biosciences Basic Information List
Table BD Biosciences Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure BD Biosciences Recombinant Antibody Global Market Share (2012-2017)
Table Beckman Coulter Basic Information List
Table Beckman Coulter Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Beckman Coulter Recombinant Antibody Global Market Share (2012-2017)
Table bioMerieux Basic Information List
Table bioMerieux Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure bioMerieux Recombinant Antibody Global Market Share (2012-2017)
Table Bio-Rad Laboratories Basic Information List
Table Bio-Rad Laboratories Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bio-Rad Laboratories Recombinant Antibody Global Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Recombinant Antibody Global Market Share (2012-2017)
Table Gallus Immunotech Basic Information List
Table Gallus Immunotech Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Gallus Immunotech Recombinant Antibody Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Antibody
Figure Manufacturing Process Analysis of Recombinant Antibody
Figure Recombinant Antibody Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2015
Table Major Buyers of Recombinant Antibody
Table Distributors/Traders List
Figure Global Recombinant Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Global Recombinant Antibody Revenue and Growth Rate Forecast (2017-2021)
Table Global Recombinant Antibody Sales Forecast by Regions (2017-2021)
Table Global Recombinant Antibody Sales Forecast by Type (2017-2021)
Table Global Recombinant Antibody Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

A.G.Scientific
Abbott Diagnostics
Agilent Technologies
BD Biosciences
Beckman Coulter
bioMerieux
Bio-Rad Laboratories
F. Hoffmann-La Roche
Gallus Immunotech
GE Healthcare
Lonza Biologics Ltd
Merck KGaA
Meridian Life Science


More Publications